San Diego's only cancer-targeting proton treatment center has leveraged an infusion of capital and new leadership to relaunch as California Protons following Chapter 11 bankruptcy.
In response to the 21st Century Cures Act, the FDA outlined its regulatory approach in guidance documents about software as a medical device.
The agency's final guidance on additive manufacturing gives developers a clear pathway for getting their 3-D printed products approved.
Guest Commentary: Community-based, tech-driven innovations can help transform an outdated health system
Outdated care models often leave families trying to manage chronic illnesses distressed, uncertain and financially strained.
The CMS has suggested major revisions to its implantable cardiac devices coverage policy to give patients faster access to the treatments. The reimbursement policies haven't been updated since 2005.
Like the rest of the healthcare industry, the medical-device industry has been consolidating at a rapid clip as companies look to increase their leverage with providers.
The nerve stimulator is the first device cleared to treat debilitating withdrawal symptoms caused by addiction to heroin and other opioids. Symptoms can include joint pain, anxiety, stomach aches and insomnia.
U.S. regulators approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.
As part of the All of Us research program, 10,000 volunteers' health indicators will be tracked by Fitbits, as the device straddles the line between consumer product and healthcare technology.
For StoneArch, versatility is the name of the game. The Minneapolis-based agency took home a lot of hardware from the 2017 Healthcare Marketing IMPACT Awards, garnering gold, silver and bronze prizes in two categories for very different clients.
High school freshmen Tyler Duke and Mason Covington are the youngest recipients of the Betty A. Lowe MD Award for outstanding service to children.
HHS' OIG called on the CMS to collect medical-device specific information as part of its claims process, a move that could help the agency quickly identify poorly performing devices.